basilar artery thrombosis/occlusion
Jump to navigation
Jump to search
Pathology
- brainstem dysfunction
- mortality 60-70%
Clinical manifestations
Management
- intra-arterial vs intravenous thrombolysis with alteplase
- endovascular thrombectomy: 40% of patients with modified Rankin Scale score of 0-3 at 90 days vs 23% of controls[3]
- angioplasty or stenting after failed endovascular thrombectomy[3]
More general terms
Additional terms
References
- ↑ Geriatrics Review Syllabus, American Geriatrics Society, 5th edition, 2002-2004
- ↑ Journal Watch 24(23):176, 2004 Lindsberg PJ, Soinne L, Tatlisumak T, Roine RO, Kallela M, Happola O, Kaste M. Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA. 2004 Oct 20;292(15):1862-6. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15494584
- ↑ 3.0 3.1 3.2 Jovin TG et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion. N Engl J Med 2022 Oct 13; 387:1373. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36239645 https://www.nejm.org/doi/10.1056/NEJMoa2207576
Tao C et al. Trial of endovascular treatment of acute basilar-artery occlusion. N Engl J Med 2022 Oct 13; 387:1361. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36239644 https://www.nejm.org/doi/10.1056/NEJMoa2206317